The goal of our study was, therefore, to evaluate the feasibility of using HP γ-glutamyl-[1-13C]glycine to monitor GGT activity in vivo in healthy rat brain and in an orthotopic glioblastoma rat model. The gene discussed is GGT1; the disease is glioblastoma.